Pfizer To Invest $200 Million in Biologics Clinical Manufacturing FacilityBy
Pfizer has broken ground for its new biologics clinical manufacturing facility in Andover, Massachusetts. Pfizer will invest more than $200 million in development of the 175,000-square-foot facility for biologics and vaccine production. The new five-story building is expected to be operational by January 2019. Approximately 75 new employees will be hired to support clinical manufacturing.
In addition to the Andover campus, Massachusetts is home to Pfizer's Research and Development hub in Cambridge. Pfizer has approximately 2,000 employees based in Massachusetts. Pfizer's Andover campus currently includes seven buildings that house laboratories, clinical and commercial manufacturing suites, and support areas. It also includes a multiproduct manufacturing facility, which allows clinical and commercial products to be manufactured simultaneously, supporting a range of Pfizer product supply.
The new clinical manufacturing facility is designed with five independent manufacturing suites and will include single-use bioreactors and disposable process technologies.